PAG Landscape Analysis for Pharma Patient Engagement
How medical affairs and patient engagement teams use PAG landscape analysis to prioritize partners and brief leadership.
PAG landscape analysis is how pharmaceutical teams turn a list of patient advocacy groups into a decision-ready view of the ecosystem — who matters, why, and where to engage first.
When teams need landscape analysis
Typical triggers:
- Pre-launch or indication expansion planning
- Rebuilding an engagement strategy after years of informal contacts
- Competitive intelligence on advocacy relationships
- Advisory board design and partner shortlisting
- Affiliate markets where local knowledge is thin
What "good" looks like
A strong patient advocacy landscape analysis should deliver:
- Coverage — the relevant universe for your scope, not a convenience sample
- Comparison — scored dimensions, not subjective rankings alone
- Context — geography, therapeutic focus, maturity, and activity signals
- Recommendations — clear shortlists tied to engagement goals
- Defensibility — sources and rationale stakeholders can review
Landscape analysis vs. mapping vs. database search
These terms overlap, but the jobs differ:
- Database — find and profile organizations (patient advocacy database)
- Mapping — structure the landscape by geography, TA, and relationships (PAG mapping)
- Landscape analysis — score, compare, and recommend (PAG landscape analysis)
Most teams need all three. Search alone is not strategy.
How PatientGroups.co approaches it
PatientGroups.co combines discovery, multi-dimensional scoring, geographic and therapeutic views, and source audit trails so landscape work becomes reusable patient advocacy intelligence — not a slide deck that expires after the steering committee meeting.
If you need a scored landscape for a launch or engagement reset, start with a scoped briefing and a shortlist your medical affairs leadership can act on.